Tuesday, August 4, 2015

In conversation with Nicole Grannell

In conversation with Nicole Grannell

August 4, 2015 by · Leave a Comment 

Tweet As vice-president of business development for Bay Area Research Logistics (BARL), a specialized clinical trial design, packaging and logistics firm, Nicole Grannell manages the logistical components of multinational clinical trials, both in developed and emerging markets. Ms. Grannell began her sales and marketing career with Big Pharma in Canada, specifically Wyeth and Boehringer Ingelheim. […]

Matinas BioPharma moves focus to anti-infectives

Matinas BioPharma moves focus to anti-infectives

July 28, 2015 by · Leave a Comment 

Tweet After moving a novel omega-3 program through a successful Phase 2 program, Matinas BioPharma Holdings (OTCQB:MTNB) is now advancing two anti-infective drug candidates in the war against drug resistance. “Our initial focus is to take powerful, but sparingly used, anti-fungal and anti-bacterial drugs and increase their safety and potency,” president and CEO, Roelof Rongen, […]

Xenon still committed to TV-45070 for neuropathic pain

Xenon still committed to TV-45070 for neuropathic pain

July 21, 2015 by · Leave a Comment 

Tweet Xenon Pharmaceuticals (NASDAQ:XENE) and its development and commercialization partner, Teva Pharmaceutical Industries (NYSE, TASE:TEVA), remain fully committed to the development of TV-45070 for neuropathic pain indications, even though it failed a Phase 2b study in pain due to osteoarthritis (OA) of the knee. “We and Teva believe that the reason the topical ointment did […]

In conversation with Heather Morehouse Ettinger

In conversation with Heather Morehouse Ettinger

July 14, 2015 by · Leave a Comment 

Tweet As a partner in the law firm of Troutman Sanders LLP, Heather Morehouse Ettinger focuses her practice on intellectual property due diligence and transaction drafting, intellectual property litigation, and patent counseling and procurement in the biotechnology and pharmaceutical fields. She regularly handles domestic and international patent portfolios, and due diligence studies for clients, including […]

M Pharma advancing technologies for obesity and diabetes

M Pharma advancing technologies for obesity and diabetes

July 7, 2015 by · Leave a Comment 

Tweet M Pharmaceutical (OTCQB:MPHMF; CSE:MQ; FWB:T3F1.F) is advancing a family of biomedical technologies to manage obesity – TriMeo and TriMtec – and eMosquito to manage diabetes. “All three of our technologies represent a spectrum of solutions with reduced invasiveness and enhanced effectiveness than currently available approved solutions,” Dr. Martin Mintchev, president and CEO, says in […]

Regenicin readying clinical trials of NovaDerm skin substitute

Regenicin readying clinical trials of NovaDerm skin substitute

June 30, 2015 by · Leave a Comment 

http://www.youtube.com/watch?v=o1ewAheYSXs’]

Tweet Regenicin (OTC:RGIN) is completing validation of its NovaDerm skin substitute at a leading institute of technology in the U.S and plans to seek FDA approval to move into clinical trials in the second half of 2015 as well as file for worldwide designation of NovaDerm as an orphan product. “We expect to be in […]

biOasis to file IND for HER2+ brain cancer treatment in 2016

biOasis to file IND for HER2+ brain cancer treatment in 2016

June 23, 2015 by · Leave a Comment 

Tweet biOasis (OTCQX:BIOAF; TSX-V:BTI) hopes to file an Investigational New Drug application with the FDA next year to begin human testing of its Transcend platform against HER2 positive brain tumors, which result from HER2+ breast cancer metastasizing to the brain. “Given the significant unmet medical need of this condition, we are in discussions for a […]

Inogen POCs represent paradigm shift in oxygen therapy

Inogen POCs represent paradigm shift in oxygen therapy

June 16, 2015 by · Leave a Comment 

http://www.youtube.com/watch?v=dbahosqqcvs’]

Tweet Inogen (NASDAQ:INGN) is continuing to convert patients with lung disease from bulky oxygen tanks that need to be refilled every two weeks to its lightweight, portable oxygen concentrator (POC) that continuously extracts oxygen from the air in the atmosphere and can be carried over the shoulder. “With POCs, patients can breathe easy while maintaining […]

Titan Pharma Phase 3 data validate ProNeura technology

Titan Pharma Phase 3 data validate ProNeura technology

June 9, 2015 by · Leave a Comment 

Tweet Titan Pharmaceuticals’ (OTCQB:TTNP) positive topline results from a Phase 3 clinical study of Probuphine, its subdermal implant of buprenorphine for the long-term maintenance treatment of opioid addiction, validate the company’s ProNeura continuous drug delivery technology. Yesterday, the company reported that the PRO-814 Phase 3 study, comparing maintenance treatment with Probuphine to treatment with a […]

KAHR Medical on financing trail to develop dual signaling proteins

KAHR Medical on financing trail to develop dual signaling proteins

June 2, 2015 by · Leave a Comment 

Tweet Closely-held KAHR Medical of Israel is seeking to raise* as much as $10-million in the U.S. and Europe to continue development of its dual signaling proteins (DSPs), including KAHR-102, its lead drug candidate for the treatment of an orphan indication in lymphoma. “The current round will fund the company’s activities until mid-2017 and will […]

Next Page »

Email Newsletters with Constant Contact
Google+